NANOTECHNOLOGY IN CANCER DRUG DELIVERY
Cancer treatment is often limited by the inability to deliver an effective drug concentration to malignant tissue without damaging healthy organs. Many anticancer medicines have poor water solubility, are rapidly removed from the circulation, or cause serious adverse effects because they distribute throughout the body. Nanotechnology offers a way to modify drug delivery by packaging medicines in very small carriers and controlling their circulation, tissue distribution and release. This review summarizes the main biological barriers encountered by nanoparticles, important lipid, polymeric, inorganic and biomimetic carrier systems, and methods used to target tumors. It also discusses carriers that respond to changes in pH, redox state, enzymes, temperature, light or ultrasound. Current applications include delivery of conventional anticancer drugs, immunemodulating agents, RNA and gene-editing systems, as well as combined imaging and treatment. Clinically used products demonstrate that nanocarriers can improve formulation properties and, in selected settings, reduce toxicity or improve therapeutic performance. However, variable tumor accumulation, immune recognition, manufacturing complexity, long-term safety and patient-topatient differences remain important obstacles. Better biological models, quality control, companion diagnostics and data-guided formulation design may help translate promising systems into reliable treatments.
Authors
- Kaufiya D. Sayyad
- Koli Kunal
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-19
- DOI
- https://doi.org/10.5281/zenodo.24362579
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00